Skip to main content

Spire Wealth Management

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1858740 MCLEAN, VA

Position in ESPR

as of Jun 30, 2026 · filed Jul 15, 2026
Position Value
$56,143
+$56,143 QoQ
Shares Held
17,767
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 40 holders
Holding Since
Mar 2021
21 quarters on record

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Spire Wealth Management holds $860,691 across 13 Drug Manufacturers - Specialty & Generic names. ESPR ranks #3 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ESPR
Esperion Therapeutics, Inc.
This page
17,767 $56,143

All Filings in ESPR

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $56,143 17,767
2026-03-31 17,767
2025-12-31 17,767
2025-09-30 17,767
2025-06-30 17,847
2025-03-31 17,767
2024-12-31 17,767
2024-09-30 17,767
2024-06-30 17,767
2024-03-31 17,767
2023-12-31 17,767
2023-09-30 10,500
2023-06-30 10,500
2023-03-31 10,500
2022-12-31 10,114
2022-09-30 10,114
2022-06-30 10,114
2022-03-31 10,114
2021-12-31 10,114
2021-06-30 100
2021-03-31 100